FDA.reportPublic FDA data

CYSTEINE HYDROCHLORIDE

Substance profile for UNII ZT934N0X4W, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for CYSTEINE HYDROCHLORIDE
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
ZT934N0X4W
Preferred term
CYSTEINE HYDROCHLORIDE
Registry number
7048-04-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C3H7NO2S.ClH.H2O
Chemical structure for CYSTEINE HYDROCHLORIDE
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
QIJRTFXNRTXDIP-JIZZDEOASA-N
SMILES
O.Cl.N[C@@H](CS)C(O)=O
RxCUI
221086
PubChem
0
NCIt
C65361
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem InChIKey SearchQIJRTFXNRTXDIP-JIZZDEOASA-Npubchem.ncbi.nlm.nih.gov/#query=QIJRTFXNRTXDIP-JIZZDEOASA-N
RxNorm221086mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=221086
NCI ThesaurusC65361ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C65361
FDA Substance Registration SystemZT934N0X4Wprecision.fda.gov/uniisearch/srs/unii/ZT934N0X4W

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
INACTIVE INGREDIENTSestamibi ( for the preparation of Tc99m Sestamibi injection)1
INACTIVE INGREDIENTMOLYHEN2
INACTIVE INGREDIENTWELLBUTRIN SR (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC]20
INACTIVE INGREDIENTACTHREL (CORTICORELIN OVINE TRIFLUTATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FERRING PHARMACEUTICALS INC.]18
INACTIVE INGREDIENTTECHNETIUM TC 99M SESTAMIBI INJECTION [MALLINCKRODT INC.]18
INACTIVE INGREDIENTZYBAN (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC]17
INACTIVE INGREDIENTCARDIOLITE (TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [LANTHEUS MEDICAL IMAGING, INC.]13
INACTIVE INGREDIENTOFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [MALLINCKRODT HOSPITAL PRODUCTS INC.]11
ACTIVE INGREDIENTPROCALAMINE (GLYCERIN, ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, GLYCINE, ARGININE, HISTIDINE, PROLINE, SERINE, CYSTEINE, SODIUM ACETATE, MAGNESIUM ACETATE, CALCIUM ACETATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, PHOSPHORIC ACID, AND POTASSIUM METABISULFITE) INJECTION [B. BRAUN MEDICAL INC.]11
ACTIVE INGREDIENTTROPHAMINE (ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE HYDROCHLORIDE, HISTIDINE, TYROSINE, N-ACETYL-TYROSINE, ALANINE, ARGININE, PROLINE, SERINE, GLYCINE, ASPARTIC ACID, GLUTAMIC ACID, AND TAURINE) SOLUTION [B. BRAUN MEDICAL INC.]11
ACTIVE INGREDIENTHEPATAMINE (ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANI) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.]8
ACTIVE INGREDIENTNEPHRAMINE (HISTIDINE, ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE, AND SODIUM BISULFITE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.]8
ACTIVE INGREDIENTFREAMINE HBC (ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, AND SODIUM BISULFITE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.]7
ACTIVE INGREDIENTFREAMINE III (ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, PHOSPHORIC ACID, AND SODIUM BISULFITE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.]7
INACTIVE INGREDIENTKIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI (TECHNETIUM TC 99M SESTAMIBI) INJECTION [DRAXIMAGE LLC]6
ACTIVE INGREDIENTL-CYSTEINE HYDROCHLORIDE INJECTION, SOLUTION [SANDOZ INC]5
INACTIVE INGREDIENTOFIRMEV (ACETAMINOPHEN) INJECTION, SOLUTION [CARDINAL HEALTH]5
INACTIVE INGREDIENTKIT FOR THE PREPARATION OF TECHNETIUM TC99M SESTAMIBI (TECHNETIUM TC-99M SESTAMIBI) INJECTION [PHARMALUCENCE, INC.]3
ACTIVE INGREDIENTL-CYSTEINE HYDROCHLORIDE INJECTION, SOLUTION [SANDOZ INC]3
INACTIVE INGREDIENTBUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [TORRENT PHARMACEUTICALS LIMITED]2
INACTIVE INGREDIENTKIT FOR THE PREPARATION OF TECHNETIUM TC99M SESTAMIBI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CARDINAL HEALTH 414, LLC]2
ACTIVE INGREDIENTPREMASOL - SULFITE-FREE (AMINO ACID) (LEUCINE, LYSINE, ISOLEUCINE, VALINE, HISTIDINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, TYROSINE, N-ACETYL-TYROSINE, ARGININE, PROLINE, ALANINE, GLUTAMIC ACIDE, SERINE, GLYCINE, ASPARTIC ACID, TAURINE, CYSTEINE HYDROCHLORIDE) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]2
INACTIVE INGREDIENTTECHNETIUM TC 99M SESTAMIBI INJECTION [MALLINCKRODT NUCLEAR MEDICINE LLC]2
INACTIVE INGREDIENTCONTRAVE (NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]1
INACTIVE INGREDIENTKIT FOR THE PREPARATION OF TECHNETIUM TC99M SESTAMIBI (TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [LANTHEUS MEDICAL IMAGING, INC.]1
ACTIVE INGREDIENTL-CYSTEINE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII ZT934N0X4W page 1 of 1 · 9 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
CYSTEINE HYDROCHLORIDEZT934N0X4W7048046INJECTIONINTRAVENOUS1.5 %w/v
CYSTEINE HYDROCHLORIDEZT934N0X4W7048046INJECTION, POWDER, FOR SOLUTIONINTRAVENOUS1 mg
CYSTEINE HYDROCHLORIDEZT934N0X4W7048046INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAVENOUS100 mg
CYSTEINE HYDROCHLORIDEZT934N0X4W7048046INJECTION, SOLUTIONINTRAVENOUS100 mg
CYSTEINE HYDROCHLORIDEZT934N0X4W7048046SOLUTIONINTRAVENOUS100 mg
CYSTEINE HYDROCHLORIDEZT934N0X4W7048046CAPSULEORALNA
CYSTEINE HYDROCHLORIDEZT934N0X4W7048046SUSPENSIONORAL3 mg
CYSTEINE HYDROCHLORIDEZT934N0X4W7048046TABLET, EXTENDED RELEASEORAL24 mg
CYSTEINE HYDROCHLORIDEZT934N0X4W7048046TABLET, FILM COATED, EXTENDED RELEASEORAL32 mg